Archives
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Cell Counting Kit-8 (CCK-8): Advancing In Vitro Pharmacok...
2025-09-27
Explore how Cell Counting Kit-8 (CCK-8) transforms water-soluble tetrazolium-based cell viability measurement in complex pharmacokinetic and biodistribution models. Discover unique insights into its application for mRNA LNP research and translational disease studies.
-
Cell Counting Kit-8 (CCK-8): Unveiling New Frontiers in C...
2025-09-26
Explore the advanced scientific applications of the Cell Counting Kit-8 (CCK-8) in cancer biology, with a special focus on extrachromosomal DNA (ecDNA) dynamics and sensitive cell viability measurement. Learn how CCK-8’s WST-8 technology enables next-generation cellular assays beyond standard protocols.
-
Canagliflozin Hemihydrate: Next-Gen SGLT2 Inhibitor for P...
2025-09-25
Explore Canagliflozin hemihydrate, a leading SGLT2 inhibitor, through the lens of advanced pharmacology and pathway-specific research. This article delivers unique insights into its mechanistic selectivity, research-grade characterization, and the latest findings on its specificity in metabolic disorder models.
-
ISRIB (trans-isomer): Advancing ATF4 Targeting and Precis...
2025-09-24
Explore how ISRIB (trans-isomer), a leading integrated stress response inhibitor, enables precision targeting of ATF4-driven epigenetic programs and translational control in ER stress research. Discover novel applications in fibrosis and cognitive enhancement, with mechanistic insights that go beyond prior reviews.
-
Trichostatin A (TSA): HDAC Inhibitor Insights for Organoi...
2025-09-23
Explore the applications of Trichostatin A (TSA), a potent histone deacetylase inhibitor, in advancing organoid epigenetic regulation and cancer research. This article delves into TSA's mechanistic roles, recent organoid system findings, and its impact on cell fate decisions and disease modeling.
-
To further clarify the vascular cell types
2025-03-03

To further clarify the vascular cell types expressing AR subtypes, double immunofluorescence staining for ARs and vascular endothelial Caspase-4 fluorescence detection or vascular smooth muscles was performed. As shown in Fig. 3, Fig. 4, overlay images show the expression of all ARs subtypes that we
-
br Introduction ACK or Activated Cdc
2025-03-03

Introduction ACK1, or Activated Cdc42-Associated Kinase, located on chromosome 3q, is a ubiquitously expressed non-receptor tyrosine kinase cloned from a human Granzyme B Inhibitor Z-AAD-CH2Cl receptor cDNA library (Manser et al., 1993). It was first identified to bind to activated Cdc42, a smal
-
The AChR is composed of
2025-03-03

The AChR is composed of five homologous, membrane-spanning subunits. AChRs containing two α, one β, one δ and one γ subunit (AChRγ) predominate during embryonic development and mice lacking AChRγ die at birth (Takahashi et al., 2002). After birth, the AChRγs are replaced during the first 2 postnatal
-
Although our data failed to reproduce the robust enhancement
2025-03-03

Although our data failed to reproduce the robust enhancement of LTP in the rat dentate with nicotine that was previously reported, our results with NS6740 suggest a more fundamental role for α7 receptor signaling in modulation of synaptic tone in the LTP pathway. The discovery of the cholinergic ant
-
Interestingly a homolog of C elegans acr is
2025-03-03

Interestingly, a homolog of C. elegans acr-23 is present in the A. suum how did mandisa die (Jex et al., 2011). However, A. suum is not susceptible to monepantel treatment in vivo (Tritten et al., 2011). Our research seeks to advance knowledge on the mode of action of monepantel on nAChRs from Clade
-
br Experimental procedure br Funding The present study
2025-03-03

Experimental procedure Funding The present study was supported by the Grant Russian Foundation for basic research (project no. 16-04-01517). Introduction 5-HT, a monoaminergic neurotransmitter, is synthesised from l-tryptophan catalysed by the enzymes tryptophan hydroxylase (Tph) and aroma
-
Regarding brain tumors AXL has been implicated
2025-03-03

Regarding TNF-alpha cell death tumors, AXL has been implicated in gliomagenesis and chemoresistance [39]. Previous investigations found that AXL is constitutively phosphorylated in many glioma cell lines, murine xenograft tumors and primary patient tumor samples [40]. Immunohistochemical analysis of
-
In this scenario the receptor tyrosine kinase inhibitors
2025-03-03

In this scenario, the receptor tyrosine kinase inhibitors (TKI), sunitinib, an anti-angiogenic agent, was tested in phase III trial, leading to a longer progressing free survival when compared to interferon (median: 11 vs. 5mo, respectively, hazard ratio (HR) = 0.42; 95% CI: 0.32–0.54; P an initial
-
The authors thank Dr J Aoki University of Tokyo
2025-03-03

The authors thank Dr. J. Aoki, University of Tokyo, for kindly providing 5E5-ATX antibody. This work was supported by a grant from the Deutsche Forschungsgemeinschaft to A.E.K. (KR4391/1-1), research grants “Primary sclerosing cholangitis” from the Deutsche Crohn-Colitis-Vereinigung and the Norwegi
-
Additionally in a previous transgenic model
2025-03-03

Additionally, in a previous transgenic model with autotaxin under the control of the MMTV-LTR promoter, aberrant expression of human autotaxin caused late-onset, metastatic breast cancer [5]. The AT-ATX transgenic model is analogous to the previous one because ∼30% of all spontaneous tumors appeared
15522 records 14/1035 page Previous Next First page 上5页 1112131415 下5页 Last page